These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34712832)

  • 1. Liver function test abnormalities in COVID-19 patients and factors affecting them - a retrospective study.
    Abdelrahman MM; Abdel-Baset AA; Younis MA; Mahmoud MG; Shafik NS
    Clin Exp Hepatol; 2021 Sep; 7(3):297-304. PubMed ID: 34712832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical predictors for Sars-Cov-2 severity.
    Gurusamy E; Mahalakshmi S; Kaarthikeyan G; Ramadevi K; Arumugam P; Gayathri MS
    Bioinformation; 2021; 17(9):834-839. PubMed ID: 35539890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of abnormal liver function tests and associated factors among COVID-19-infected patients in Addis Ababa, Ethiopia, 2022: a facility-based comparative cross-sectional study.
    Mekuanint A; Ambachew S; Worede A; Asrie F; Sinishaw MA; Gelaw Y; Dagnew M; Gelaw A; Negash M; Kassa E; Bizuneh S; Wudineh D; Dimah B; Abebe W; Chane E; Fetene G
    BMJ Open; 2024 Sep; 14(9):e076647. PubMed ID: 39260868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver function test abnormalities at hospital admission are associated with severe course of SARS-CoV-2 infection: a prospective cohort study.
    Weber S; Hellmuth JC; Scherer C; Muenchhoff M; Mayerle J; Gerbes AL
    Gut; 2021 Oct; 70(10):1925-1932. PubMed ID: 33514597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does Raised Transaminases Predict Severity and Mortality in Patients with COVID 19?
    Kodavoor Vadiraj P; Thareja S; Raman N; Karantha SC; Jayaraman M; Vardhan V
    J Clin Exp Hepatol; 2022; 12(4):1114-1123. PubMed ID: 35125781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical features and risk factors for secondary hemophagocytic lymphohistiocytosis in elderly patients with severe SARS-CoV-2 infection: a multicenter retrospective cohort study].
    Deng Y; Lu S; Zhang G; Sun W; Chu Y; Meng M; Cui Y; Li P
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Aug; 35(8):793-799. PubMed ID: 37593855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 12-Month Post-Discharge Liver Function Test Abnormalities Among Patients With COVID-19: A Single-Center Prospective Cohort Study.
    Liao X; Li D; Ma Z; Zhang L; Zheng B; Li Z; Li G; Liu L; Zhang Z
    Front Cell Infect Microbiol; 2022; 12():864933. PubMed ID: 35493732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of clinically relevant serum proteins as biomarkers for monitoring COVID-19 severity, and end-organ damage among hospitalized unvaccinated patients.
    Elhommosani MR; Sakr MM; Abbas RM; Aboshanab KM
    BMC Infect Dis; 2024 Feb; 24(1):231. PubMed ID: 38378528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated liver enzymes portends a higher rate of complication and death in SARS-CoV-2.
    Currier EE; Dabaja M; Jafri SM
    World J Hepatol; 2021 Sep; 13(9):1181-1189. PubMed ID: 34630884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver function test abnormalities are associated with a poorer prognosis in Covid-19 patients: Results of a French cohort.
    Chaibi S; Boussier J; Hajj WE; Abitbol Y; Taieb S; Horaist C; Jouannaud V; Wang P; Piquet J; Maurer C; Lahmek P; Nahon S
    Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101556. PubMed ID: 33139241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronavirus disease (COVID-19) and the liver: a comprehensive systematic review and meta-analysis.
    Kumar-M P; Mishra S; Jha DK; Shukla J; Choudhury A; Mohindra R; Mandavdhare HS; Dutta U; Sharma V
    Hepatol Int; 2020 Sep; 14(5):711-722. PubMed ID: 32623633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pattern of liver function test variations in COVID-19 infection & its clinical significance: A study from a dedicated COVID-19 tertiary care centre from India.
    Chandnani SJ; Jain S; Nawghare P; Debnath P; Rane S; Deshmukh R; Bansal S; Patel S; Thanage R; Junare P; Contractor Q; Rathi PM; Singh AK
    Indian J Med Res; 2022 Sep; 156(3):484-499. PubMed ID: 36751745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of baseline liver biochemical parameters in 324 cases with novel coronavirus pneumonia in Shanghai area].
    Qian ZP; Mei X; Zhang YY; Zou Y; Zhang ZG; Zhu H; Guo HY; Liu Y; Ling Y; Zhang XY; Wang JF; Lu HZ
    Zhonghua Gan Zang Bing Za Zhi; 2020 Mar; 28(3):229-233. PubMed ID: 32270660
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical characteristics of factory workers with asymptomatic liver function test abnormalities found on serial health examination].
    Kim KM; Kim YJ; Lee KH; Paek D
    Korean J Hepatol; 2005 Jun; 11(2):144-56. PubMed ID: 15980673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical, biochemical and pulmonary CT imaging features for hepatobiliary involvement in COVID-19.
    Dumea E; Barbu EC; Chiţu CE; Lazăr M; Ion DA
    Germs; 2023 Jun; 13(2):121-129. PubMed ID: 38144251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Significance of Liver Function Abnormality in Patients with COVID-19: A Single-center Experience from Western India.
    Kalal CR; Joshi H; Kumar V; Gopal D; Rathod D; Shukla A; Gianchandani T; Bhatt C
    J Clin Transl Hepatol; 2021 Dec; 9(6):878-888. PubMed ID: 34966651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of ankylosing spondylitis with TNF inhibitors does not have adverse effect on results of liver function tests: a longitudinal study.
    Capkin E; Karkucak M; Cosar AM; Ak E; Karaca A; Gokmen F; Budak BS; Tosun M
    Int J Rheum Dis; 2015 Jun; 18(5):548-52. PubMed ID: 24612551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II).
    Ye Q; Wang H; Xia X; Zhou C; Liu Z; Xia ZE; Zhang Z; Zhao Y; Yehenala J; Wang S; Zhou G; Hu K; Wu B; Wu CT; Wang S; He Y
    Trials; 2020 Jun; 21(1):520. PubMed ID: 32532356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of baseline abnormal liver enzymes in the outcome of COVID-19 infection.
    Farias JP; Codes L; Vinhaes D; Amorim AP; D'Oliveira RC; Farias AQ; Bittencourt PL
    Transl Gastroenterol Hepatol; 2023; 8():5. PubMed ID: 36704646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver function tests in COVID 19: A retrospective record-based study from a tertiary care centre in urban Maharashtra, India.
    Kumar D; Srivastava S; Rajnikant T; Dawra S; Tevatia MS; Mukherjee R
    Med J Armed Forces India; 2022 May; 79(Suppl 1):S131-5. PubMed ID: 35582519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.